Overview

A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This was a Phase III, open-label, single-arm study that was conducted at 43 centers in the United States and Canada. 251 adult and pediatric patients with dysfunctional central venous catheters (CVCs) were enrolled in the study and treated with one or two doses of tenecteplase.
Phase:
Phase 3
Details
Lead Sponsor:
Genentech, Inc.
Treatments:
Tenecteplase
Tissue Plasminogen Activator